Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Capex-to-Operating-Income : 3.91 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Vaidyane Ayurved Laboratories's Capital Expenditure for the six months ended in Mar. 2024 was ₹-42.16 Mil. Its Operating Income for the six months ended in Mar. 2024 was ₹10.78 Mil.

Hence, Vaidyane Ayurved Laboratories's Capex-to-Operating-Income for the six months ended in Mar. 2024 was 3.91.

Vaidyane Ayurved Laboratories Capex-to-Operating-Income Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Capex-to-Operating-Income Chart

Vaidyane Ayurved Laboratories Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Capex-to-Operating-Income

Get a 7-Day Free Trial

5.65

0.45

0.63

1.18

5.12

Vaidyane Ayurved Laboratories Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Capex-to-Operating-Income	Get a 7-Day Free Trial				0.68	0.82	1.54	6.32	3.91

Competitive Comparison of Vaidyane Ayurved Laboratories's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaidyane Ayurved Laboratories's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Capex-to-Operating-Income falls into.

Save Embed

;

Save Embed

;

Vaidyane Ayurved Laboratories Capex-to-Operating-Income Calculation

Vaidyane Ayurved Laboratories's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-111.419)	/	21.746
	=	5.12

Vaidyane Ayurved Laboratories's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-42.159)	/	10.779
	=	3.91

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Vaidyane Ayurved Laboratories Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaidyane Ayurved Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Capex-to-Operating-Income

Traded in Other Exchanges

N/A

Address

201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604

Website

https://www.madhavbaug.org

Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines